$8.67
-0.30 (-3.34%)
BioCryst Pharmaceuticals, Inc. (BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

RSS Headlines
Fool UK